Related Experiment Video
Updated: Feb 11, 2026

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
Published on: September 25, 2017
Vascular calcification and left ventricular hypertrophy in hemodialysis patients: interrelationship and clinical
Hyeon Seok Hwang1, Jung Sun Cho2, Yu Ah Hong1
1Division of Nephrology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea.
Insights
Vascular calcification (VC) and left ventricular hypertrophy (LVH) together significantly increase cardiovascular event risk in hemodialysis patients, showing a synergistic effect on mortality and events.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Vascular calcification (VC) and left ventricular hypertrophy (LVH) are common in hemodialysis (HD) patients.
- The combined impact of VC and LVH on adverse outcomes in HD patients requires further investigation.
Purpose of the Study:
- To examine the relationship between VC and LVH.
- To evaluate the combined effect of VC and LVH on deaths and cardiovascular events (CVEs) in maintenance HD patients.
Main Methods:
- 341 maintenance HD patients were analyzed.
- Echocardiography and plain chest radiographs were used to assess LVH and aortic arch VC.
- Multivariate analysis was performed to determine independent associations and interactions.
Main Results:
- VC was present in 29.3% of patients and independently associated with a 2.42-fold increased risk of LVH.
- The coexistence of VC and LVH was independently associated with CVEs (HR, 2.01) and composite deaths or CVEs (HR, 1.88).
- VC or LVH alone did not independently associate with CVEs, but showed significant synergistic interaction for composite events (P=0.039).
Conclusions:
- VC is independently associated with LVH in HD patients.
- The combination of VC and LVH poses a higher risk for deaths and CVEs compared to either condition alone.
- VC and LVH exhibit a synergistic interaction, amplifying the risk of adverse cardiovascular outcomes in HD patients.
Abstract:
Background: We examined the relationship and combined effect of vascular calcification (VC) and left ventricular hypertrophy (LVH) on deaths and cardiovascular events (CVEs) in hemodialysis (HD) patients. Methods: Maintenance HD patients (n=341) were included. Echocardiography data and plain chest radiographs were used to assess LVH and aortic arch VC. Results: VC was found in 100 patients (29.3%). LVH was more prevalent in patients with VC compared with those without VC (70% vs. 50.2%, P=0.001). VC was independently associated with a 2.42-fold increased risk of LVH (95% CI, 1.26-4.65). In multivariate analysis, compared with patients with neither VC nor LVH, the coexistence of VC and LVH was independently associated with CVE (HR, 2.01; 95% CI, 1.09-3.72), whereas VC or LVH alone was not. Patients with both VC and LVH had the highest risk for a composite event of deaths or CVE (HR, 1.88; 95% CI, 1.15-3.06). Significant synergistic interaction was observed between VC and LVH (P for interaction=0.039). Conclusions: VC was independently associated with LVH. The coexistence of VC and LVH was associated with higher risk of deaths and CVEs than either factor alone. VC and LVH showed a synergistic interaction for the risk of deaths and CVEs.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Impact of Groups on Groups
Seedless Vascular Plants
Impact
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...

